_id

6911c5e7ccc777a4e85d6535

Ticker

HMDCF

Name

HUTCHMED (China) Limited

Exchange

PINK

Address

Cheung Kong Center, Hong Kong, Hong Kong

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.hutch-med.com

Description

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

Last Close

3.66

Volume

-

Current Price

3.188

Change

0

Last Updated

2026-01-04T14:33:32.401Z

Image

-

Ipo Date

-

Market Cap

3145255424

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.44675

Sentiment Sources

4

Current Quarter

2025-06-30

Revenue

138838500

Cost Of Revenue

83788500

Gross Profit

55050000

Operating Expenses

56807000

Operating Income

-1757000

Interest Expense

-

Pretax Income

259358500

Net Income

227477000

Eps

0.26069934842743253

Dividends Per Share

-

Shares Outstanding

859359392

Income Tax Expense

31581000

EBITDA

1302000

Operating Margin

-1.265499123081854

Total Other Income Expense Net

261115500

Cash

1364520000

Short Term Investments

1254926000

Receivables

146967000

Inventories

-

Total Current Assets

1592327000

Property Plant Equipment

94573000

Total Assets

1775940000

Payables

43725000

Short Term Debt

29700000

Long Term Debt

93444000

Total Liabilities

534017000

Equity

1229064000

Bs_currency_symbol

USD

Depreciation

3059000

Change In Working Capital

-15654000

Cash From Operations

-36447000

Capital Expenditures

4633500

Cash From Investing

8796500

Cash From Financing

4660500

Net Change In Cash

-

Cf_currency_symbol

-

PE

6.9057

PB

2.263296026442887

ROE

18.508149290842464

ROA

12.808822370125117

FCF

-41080500

Fcf Percent

-0.2958869477846563

Piotroski FScore

2

Health Score

73

Deep Value Investing Score

7

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

10

Garp Investing Score

3.5

Growth Investing Score

2

Momentum Investing Score

4.5

Net Net Investing Score

1.5

Quality Investing Score

6

Value Investing Score

8.5

Quarters > 0 > quarter

2025-06-30

Quarters > 0 > income Statement > revenue

138838500

Quarters > 0 > income Statement > cost Of Revenue

83788500

Quarters > 0 > income Statement > gross Profit

55050000

Quarters > 0 > income Statement > operating Expenses

56807000

Quarters > 0 > income Statement > operating Income

-1757000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

259358500

Quarters > 0 > income Statement > net Income

227477000

Quarters > 0 > income Statement > eps

0.26069934842743253

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

872564513

Quarters > 0 > income Statement > income Tax Expense

31581000

Quarters > 0 > income Statement > EBITDA

1302000

Quarters > 0 > income Statement > operating Margin

-1.265499123081854

Quarters > 0 > income Statement > total Other Income Expense Net

261115500

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

1364520000

Quarters > 0 > balance Sheet > short Term Investments

1254926000

Quarters > 0 > balance Sheet > receivables

146967000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

1592327000

Quarters > 0 > balance Sheet > property Plant Equipment

94573000

Quarters > 0 > balance Sheet > total Assets

1775940000

Quarters > 0 > balance Sheet > payables

43725000

Quarters > 0 > balance Sheet > short Term Debt

29700000

Quarters > 0 > balance Sheet > long Term Debt

93444000

Quarters > 0 > balance Sheet > total Liabilities

534017000

Quarters > 0 > balance Sheet > equity

1229064000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

227477000

Quarters > 0 > cash Flow > depreciation

3059000

Quarters > 0 > cash Flow > change In Working Capital

-15654000

Quarters > 0 > cash Flow > cash From Operations

-36447000

Quarters > 0 > cash Flow > capital Expenditures

4633500

Quarters > 0 > cash Flow > cash From Investing

8796500

Quarters > 0 > cash Flow > cash From Financing

4660500

Quarters > 0 > cash Flow > net Change In Cash

-

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

0.26069934842743253

Quarters > 0 > ratios > PB

2.263296026442887

Quarters > 0 > ratios > ROE

18.508149290842464

Quarters > 0 > ratios > ROA

12.808822370125117

Quarters > 0 > ratios > FCF

-41080500

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-0.2958869477846563

Quarters > 0 > health Score

73

Quarters > 1 > quarter

2025-03-31

Quarters > 1 > income Statement > revenue

138838500

Quarters > 1 > income Statement > cost Of Revenue

83788500

Quarters > 1 > income Statement > gross Profit

55050000

Quarters > 1 > income Statement > operating Expenses

56807000

Quarters > 1 > income Statement > operating Income

-1757000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

259358500

Quarters > 1 > income Statement > net Income

227477000

Quarters > 1 > income Statement > eps

0.26069934842743253

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

872564513

Quarters > 1 > income Statement > income Tax Expense

31581000

Quarters > 1 > income Statement > EBITDA

1302000

Quarters > 1 > income Statement > operating Margin

-1.265499123081854

Quarters > 1 > income Statement > total Other Income Expense Net

261115500

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

110719000

Quarters > 1 > balance Sheet > short Term Investments

1254926000

Quarters > 1 > balance Sheet > receivables

146967000

Quarters > 1 > balance Sheet > inventories

48454000

Quarters > 1 > balance Sheet > total Current Assets

1592327000

Quarters > 1 > balance Sheet > property Plant Equipment

94573000

Quarters > 1 > balance Sheet > total Assets

1775940000

Quarters > 1 > balance Sheet > payables

43725000

Quarters > 1 > balance Sheet > short Term Debt

29700000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

534017000

Quarters > 1 > balance Sheet > equity

1229064000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

227477000

Quarters > 1 > cash Flow > depreciation

3059000

Quarters > 1 > cash Flow > change In Working Capital

-15654000

Quarters > 1 > cash Flow > cash From Operations

-36447000

Quarters > 1 > cash Flow > capital Expenditures

4633500

Quarters > 1 > cash Flow > cash From Investing

8796500

Quarters > 1 > cash Flow > cash From Financing

4660500

Quarters > 1 > cash Flow > net Change In Cash

-

Quarters > 1 > cash Flow > currency_symbol

-

Quarters > 1 > ratios > PE

0.26069934842743253

Quarters > 1 > ratios > PB

2.263296026442887

Quarters > 1 > ratios > ROE

18.508149290842464

Quarters > 1 > ratios > ROA

12.808822370125117

Quarters > 1 > ratios > FCF

-41080500

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

-0.2958869477846563

Quarters > 1 > health Score

73

Quarters > 2 > quarter

2024-12-31

Quarters > 2 > income Statement > revenue

162260000

Quarters > 2 > income Statement > cost Of Revenue

190429000

Quarters > 2 > income Statement > gross Profit

-28169000

Quarters > 2 > income Statement > operating Expenses

-20077000

Quarters > 2 > income Statement > operating Income

-8092000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

8155500

Quarters > 2 > income Statement > net Income

5964000

Quarters > 2 > income Statement > eps

0.006830646529902371

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

873123792

Quarters > 2 > income Statement > income Tax Expense

2153000

Quarters > 2 > income Statement > EBITDA

-5047500

Quarters > 2 > income Statement > operating Margin

-4.987057808455566

Quarters > 2 > income Statement > total Other Income Expense Net

16247500

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

153958000

Quarters > 2 > balance Sheet > short Term Investments

682152000

Quarters > 2 > balance Sheet > receivables

167743000

Quarters > 2 > balance Sheet > inventories

50400000

Quarters > 2 > balance Sheet > total Current Assets

1066555000

Quarters > 2 > balance Sheet > property Plant Equipment

96995000

Quarters > 2 > balance Sheet > total Assets

1274196000

Quarters > 2 > balance Sheet > payables

42521000

Quarters > 2 > balance Sheet > short Term Debt

26297000

Quarters > 2 > balance Sheet > long Term Debt

59434000

Quarters > 2 > balance Sheet > total Liabilities

502343000

Quarters > 2 > balance Sheet > equity

759929000

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

5964000

Quarters > 2 > cash Flow > depreciation

3044500

Quarters > 2 > cash Flow > change In Working Capital

-613000

Quarters > 2 > cash Flow > cash From Operations

20164500

Quarters > 2 > cash Flow > capital Expenditures

3912500

Quarters > 2 > cash Flow > cash From Investing

-45312500

Quarters > 2 > cash Flow > cash From Financing

947500

Quarters > 2 > cash Flow > net Change In Cash

-

Quarters > 2 > cash Flow > currency_symbol

-

Quarters > 2 > ratios > PE

0.006830646529902371

Quarters > 2 > ratios > PB

3.6628667268863278

Quarters > 2 > ratios > ROE

0.7848101598965167

Quarters > 2 > ratios > ROA

0.4680598589228031

Quarters > 2 > ratios > FCF

16252000

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.10016023665721681

Quarters > 2 > health Score

52

Quarters > 3 > quarter

2024-09-30

Quarters > 3 > income Statement > revenue

162260000

Quarters > 3 > income Statement > cost Of Revenue

190429000

Quarters > 3 > income Statement > gross Profit

-28169000

Quarters > 3 > income Statement > operating Expenses

-20077000

Quarters > 3 > income Statement > operating Income

-8092000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

8155500

Quarters > 3 > income Statement > net Income

5964000

Quarters > 3 > income Statement > eps

0.006830646529902371

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

873123792

Quarters > 3 > income Statement > income Tax Expense

2153000

Quarters > 3 > income Statement > EBITDA

-5047500

Quarters > 3 > income Statement > operating Margin

-4.987057808455566

Quarters > 3 > income Statement > total Other Income Expense Net

16247500

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

153958000

Quarters > 3 > balance Sheet > short Term Investments

684799000

Quarters > 3 > balance Sheet > receivables

155537000

Quarters > 3 > balance Sheet > inventories

50400000

Quarters > 3 > balance Sheet > total Current Assets

1066555000

Quarters > 3 > balance Sheet > property Plant Equipment

96995000

Quarters > 3 > balance Sheet > total Assets

1274196000

Quarters > 3 > balance Sheet > payables

42521000

Quarters > 3 > balance Sheet > short Term Debt

26297000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

502343000

Quarters > 3 > balance Sheet > equity

759929000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

5964000

Quarters > 3 > cash Flow > depreciation

3044500

Quarters > 3 > cash Flow > change In Working Capital

-613000

Quarters > 3 > cash Flow > cash From Operations

20164500

Quarters > 3 > cash Flow > capital Expenditures

3912500

Quarters > 3 > cash Flow > cash From Investing

-45312500

Quarters > 3 > cash Flow > cash From Financing

947500

Quarters > 3 > cash Flow > net Change In Cash

-203953000

Quarters > 3 > cash Flow > currency_symbol

-

Quarters > 3 > ratios > PE

0.006830646529902371

Quarters > 3 > ratios > PB

3.6628667268863278

Quarters > 3 > ratios > ROE

0.7848101598965167

Quarters > 3 > ratios > ROA

0.4680598589228031

Quarters > 3 > ratios > FCF

16252000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.10016023665721681

Quarters > 3 > health Score

52

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

630201000

Annuals > 0 > income Statement > cost Of Revenue

348884000

Annuals > 0 > income Statement > gross Profit

281317000

Annuals > 0 > income Statement > operating Expenses

321927000

Annuals > 0 > income Statement > operating Income

-40610000

Annuals > 0 > income Statement > interest Expense

2872000

Annuals > 0 > income Statement > pretax Income

45362000

Annuals > 0 > income Statement > net Income

37729000

Annuals > 0 > income Statement > eps

0.04322610090158895

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

872829129

Annuals > 0 > income Statement > income Tax Expense

7192000

Annuals > 0 > income Statement > EBITDA

14163624

Annuals > 0 > income Statement > operating Margin

-6.443975810892081

Annuals > 0 > income Statement > total Other Income Expense Net

85972000

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

153958000

Annuals > 0 > balance Sheet > short Term Investments

682152000

Annuals > 0 > balance Sheet > receivables

167743000

Annuals > 0 > balance Sheet > inventories

50378822

Annuals > 0 > balance Sheet > total Current Assets

1066555000

Annuals > 0 > balance Sheet > property Plant Equipment

96954243

Annuals > 0 > balance Sheet > total Assets

1274196000

Annuals > 0 > balance Sheet > payables

42521000

Annuals > 0 > balance Sheet > short Term Debt

26297000

Annuals > 0 > balance Sheet > long Term Debt

59434000

Annuals > 0 > balance Sheet > total Liabilities

502343000

Annuals > 0 > balance Sheet > equity

759929000

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

37883124

Annuals > 0 > cash Flow > depreciation

12341000

Annuals > 0 > cash Flow > change In Working Capital

-62422963

Annuals > 0 > cash Flow > cash From Operations

497000

Annuals > 0 > cash Flow > capital Expenditures

17933000

Annuals > 0 > cash Flow > cash From Investing

-96060000

Annuals > 0 > cash Flow > cash From Financing

-30667000

Annuals > 0 > cash Flow > net Change In Cash

-129631000

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

0.04322610090158895

Annuals > 0 > ratios > PB

4.203754050891597

Annuals > 0 > ratios > ROE

4.964805922658564

Annuals > 0 > ratios > ROA

2.961004429459832

Annuals > 0 > ratios > FCF

-17436000

Annuals > 0 > ratios > Piotroski FScore

4

Annuals > 0 > ratios > fcf Percent

-0.027667363269813918

Annuals > 0 > health Score

49

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

837999000

Annuals > 1 > income Statement > cost Of Revenue

384447000

Annuals > 1 > income Statement > gross Profit

453552000

Annuals > 1 > income Statement > operating Expenses

432043000

Annuals > 1 > income Statement > operating Income

18375000

Annuals > 1 > income Statement > interest Expense

759000

Annuals > 1 > income Statement > pretax Income

105603000

Annuals > 1 > income Statement > net Income

100780000

Annuals > 1 > income Statement > eps

0.11594618434821127

Annuals > 1 > income Statement > dividends Per Share

15

Annuals > 1 > income Statement > shares Outstanding

869196348

Annuals > 1 > income Statement > income Tax Expense

4509000

Annuals > 1 > income Statement > EBITDA

67431387

Annuals > 1 > income Statement > operating Margin

2.1927233803381627

Annuals > 1 > income Statement > total Other Income Expense Net

87228000

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

283589000

Annuals > 1 > balance Sheet > short Term Investments

602747000

Annuals > 1 > balance Sheet > receivables

116894000

Annuals > 1 > balance Sheet > inventories

50258000

Annuals > 1 > balance Sheet > total Current Assets

1096839000

Annuals > 1 > balance Sheet > property Plant Equipment

104363673

Annuals > 1 > balance Sheet > total Assets

1279773000

Annuals > 1 > balance Sheet > payables

36327000

Annuals > 1 > balance Sheet > short Term Debt

35082000

Annuals > 1 > balance Sheet > long Term Debt

48189000

Annuals > 1 > balance Sheet > total Liabilities

536386000

Annuals > 1 > balance Sheet > equity

730541000

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

100780000

Annuals > 1 > cash Flow > depreciation

8207000

Annuals > 1 > cash Flow > change In Working Capital

-16122000

Annuals > 1 > cash Flow > cash From Operations

219258000

Annuals > 1 > cash Flow > capital Expenditures

32612000

Annuals > 1 > cash Flow > cash From Investing

-291136000

Annuals > 1 > cash Flow > cash From Financing

48660000

Annuals > 1 > cash Flow > net Change In Cash

-29689000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

0.11594618434821127

Annuals > 1 > ratios > PB

4.354661317681006

Annuals > 1 > ratios > ROE

13.795255844641163

Annuals > 1 > ratios > ROA

7.874834052601516

Annuals > 1 > ratios > FCF

186646000

Annuals > 1 > ratios > Piotroski FScore

4

Annuals > 1 > ratios > fcf Percent

0.22272818941311387

Annuals > 1 > health Score

79

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

426409000

Annuals > 2 > income Statement > cost Of Revenue

311103000

Annuals > 2 > income Statement > gross Profit

115306000

Annuals > 2 > income Statement > operating Expenses

522999000

Annuals > 2 > income Statement > operating Income

-413230530

Annuals > 2 > income Statement > interest Expense

652000

Annuals > 2 > income Statement > pretax Income

-361527723

Annuals > 2 > income Statement > net Income

-360835000

Annuals > 2 > income Statement > eps

-0.4259431642481745

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

847143540

Annuals > 2 > income Statement > income Tax Expense

-283000

Annuals > 2 > income Statement > EBITDA

-402061000

Annuals > 2 > income Statement > operating Margin

-96.9094296790171

Annuals > 2 > income Statement > total Other Income Expense Net

51702807

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

313278000

Annuals > 2 > balance Sheet > short Term Investments

317718000

Annuals > 2 > balance Sheet > receivables

126610425

Annuals > 2 > balance Sheet > inventories

56690000

Annuals > 2 > balance Sheet > total Current Assets

839888000

Annuals > 2 > balance Sheet > property Plant Equipment

84669000

Annuals > 2 > balance Sheet > total Assets

1029445000

Annuals > 2 > balance Sheet > payables

71115000

Annuals > 2 > balance Sheet > short Term Debt

7412705

Annuals > 2 > balance Sheet > long Term Debt

18104000

Annuals > 2 > balance Sheet > total Liabilities

392575000

Annuals > 2 > balance Sheet > equity

610367000

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-360386000

Annuals > 2 > cash Flow > depreciation

8664000

Annuals > 2 > cash Flow > change In Working Capital

58704000

Annuals > 2 > cash Flow > cash From Operations

-268599000

Annuals > 2 > cash Flow > capital Expenditures

36664000

Annuals > 2 > cash Flow > cash From Investing

296588000

Annuals > 2 > cash Flow > cash From Financing

-82763000

Annuals > 2 > cash Flow > net Change In Cash

-64264000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-0.4259431642481745

Annuals > 2 > ratios > PB

5.079805029433111

Annuals > 2 > ratios > ROE

-59.11771114755548

Annuals > 2 > ratios > ROA

-35.05141119729563

Annuals > 2 > ratios > FCF

-305263000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-0.7158924881979508

Annuals > 2 > health Score

25

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

356128000

Annuals > 3 > income Statement > cost Of Revenue

258234000

Annuals > 3 > income Statement > gross Profit

97894000

Annuals > 3 > income Statement > operating Expenses

426211000

Annuals > 3 > income Statement > operating Income

-342701109

Annuals > 3 > income Statement > interest Expense

592000

Annuals > 3 > income Statement > pretax Income

-154612789

Annuals > 3 > income Statement > net Income

-194648000

Annuals > 3 > income Statement > eps

-0.24555544369376386

Annuals > 3 > income Statement > dividends Per Share

577095

Annuals > 3 > income Statement > shares Outstanding

792684524

Annuals > 3 > income Statement > income Tax Expense

11918000

Annuals > 3 > income Statement > EBITDA

-207274009

Annuals > 3 > income Statement > operating Margin

-96.22975699748405

Annuals > 3 > income Statement > total Other Income Expense Net

188088320

Annuals > 3 > income Statement > currency_symbol

USD

Annuals > 3 > balance Sheet > cash

377542000

Annuals > 3 > balance Sheet > short Term Investments

634158000

Annuals > 3 > balance Sheet > receivables

132622000

Annuals > 3 > balance Sheet > inventories

35755000

Annuals > 3 > balance Sheet > total Current Assets

1212076000

Annuals > 3 > balance Sheet > property Plant Equipment

66323000

Annuals > 3 > balance Sheet > total Assets

1372661000

Annuals > 3 > balance Sheet > payables

41177000

Annuals > 3 > balance Sheet > short Term Debt

31822000

Annuals > 3 > balance Sheet > long Term Debt

0

Annuals > 3 > balance Sheet > total Liabilities

333147000

Annuals > 3 > balance Sheet > equity

986893000

Annuals > 3 > balance Sheet > currency_symbol

USD

Annuals > 3 > cash Flow > net Income

-167041000

Annuals > 3 > cash Flow > depreciation

7190000

Annuals > 3 > cash Flow > change In Working Capital

32458000

Annuals > 3 > cash Flow > cash From Operations

-204223000

Annuals > 3 > cash Flow > capital Expenditures

16756000

Annuals > 3 > cash Flow > cash From Investing

-306320000

Annuals > 3 > cash Flow > cash From Financing

650028000

Annuals > 3 > cash Flow > net Change In Cash

141912000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-0.24555544369376386

Annuals > 3 > ratios > PB

2.9397567495564365

Annuals > 3 > ratios > ROE

-19.72331346964666

Annuals > 3 > ratios > ROA

-14.18034022967069

Annuals > 3 > ratios > FCF

-220979000

Annuals > 3 > ratios > Piotroski FScore

1

Annuals > 3 > ratios > fcf Percent

-0.620504425375146

Annuals > 3 > health Score

35

Valuation > metrics > PE

6.9057

Valuation > metrics > PB

2.263296026442887

Valuation > final Score

100

Valuation > verdict

15.5% Undervalued

Profitability > metrics > ROE

18.508149290842464

Profitability > metrics > ROA

14.285821944864342

Profitability > metrics > Net Margin

1.6384288219766132

Profitability > final Score

97

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

0.434490799502711

Risk > metrics > Interest Coverage

-0.006808586491717899

Risk > final Score

60

Risk > verdict

High

Liquidity > metrics > Current Ratio

21.686441947565545

Liquidity > metrics > Quick Ratio

21.686441947565545

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

100

Prev Valuations > 1

63.371332731136725

Prev Valuations > 2

63.371332731136725

Prev Profitabilities > 0

97

Prev Profitabilities > 1

9

Prev Profitabilities > 2

9

Prev Risks > 0

60

Prev Risks > 1

46

Prev Risks > 2

46

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T21:58:36.500Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-03-23

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-

Earnings History > 1 > period

2021-06-30

Earnings History > 1 > report Date

2021-08-17

Earnings History > 1 > date

2021-06-30

Earnings History > 1 > before After Market

-

Earnings History > 1 > currency

USD

Earnings History > 1 > eps Actual

-0.0835

Earnings History > 1 > eps Estimate

-

Earnings History > 1 > eps Difference

0

Earnings History > 1 > surprise Percent

-

Earnings History > 2 > period

2021-03-31

Earnings History > 2 > report Date

2021-06-17

Earnings History > 2 > date

2021-03-31

Earnings History > 2 > before After Market

AfterMarket

Earnings History > 2 > currency

USD

Earnings History > 2 > eps Actual

-0.0569

Earnings History > 2 > eps Estimate

-

Earnings History > 2 > eps Difference

0

Earnings History > 2 > surprise Percent

-

Earnings History > 3 > period

2020-03-31

Earnings History > 3 > report Date

2020-03-31

Earnings History > 3 > date

2020-03-31

Earnings History > 3 > before After Market

-

Earnings History > 3 > currency

USD

Earnings History > 3 > eps Actual

-0.0236

Earnings History > 3 > eps Estimate

-

Earnings History > 3 > eps Difference

0

Earnings History > 3 > surprise Percent

-

Earnings History > 4 > period

2019-12-31

Earnings History > 4 > report Date

2019-12-31

Earnings History > 4 > date

2019-12-31

Earnings History > 4 > before After Market

-

Earnings History > 4 > currency

USD

Earnings History > 4 > eps Actual

-0.0443

Earnings History > 4 > eps Estimate

-

Earnings History > 4 > eps Difference

0

Earnings History > 4 > surprise Percent

-

Earnings History > 5 > period

2019-09-30

Earnings History > 5 > report Date

2019-09-30

Earnings History > 5 > date

2019-09-30

Earnings History > 5 > before After Market

-

Earnings History > 5 > currency

USD

Earnings History > 5 > eps Actual

-0.0466

Earnings History > 5 > eps Estimate

-

Earnings History > 5 > eps Difference

0

Earnings History > 5 > surprise Percent

-

Earnings History > 6 > period

2019-06-30

Earnings History > 6 > report Date

2019-06-30

Earnings History > 6 > date

2019-06-30

Earnings History > 6 > before After Market

-

Earnings History > 6 > currency

USD

Earnings History > 6 > eps Actual

-0.0382

Earnings History > 6 > eps Estimate

-

Earnings History > 6 > eps Difference

0

Earnings History > 6 > surprise Percent

-

Earnings History > 7 > period

2019-03-31

Earnings History > 7 > report Date

2019-03-31

Earnings History > 7 > date

2019-03-31

Earnings History > 7 > before After Market

-

Earnings History > 7 > currency

USD

Earnings History > 7 > eps Actual

-0.2988

Earnings History > 7 > eps Estimate

-

Earnings History > 7 > eps Difference

0

Earnings History > 7 > surprise Percent

-